When did you last sit down with your distributor and review every product in your current portfolio? Not a case debrief. Not a product introduction. A structured conversation covering what is working, what is not, what your outcomes data shows, and whether the devices you are using today are still the best options available for the patients you are treating.

Most surgeons have not done this recently. Most distributor relationships do not include it as a standard touchpoint. The quarterly portfolio review is one of the most underused tools in surgical practice management, and it is one of the highest-value conversations a surgeon and their medical sales consultant can have.

What a quarterly review covers

A productive quarterly review is not a social call. It covers four areas with specificity. First, outcomes: what do your case results over the past quarter show about device performance across your most common procedures? Second, utilisation: are there products in your portfolio you are using less than expected, and is that a clinical signal or a workflow issue? Third, new evidence: has any published data emerged in the past quarter that affects how you would evaluate a device you are currently using? Fourth, pipeline: what is your distributor carrying or planning to introduce that is relevant to your patient population?

Those four areas take forty-five minutes to cover thoroughly. The conversation they generate is worth far more than the time it takes.

How to make the distributor accountable

The quarterly review only works if the distributor prepares for it with the same seriousness that the surgeon brings. That means arriving with updated clinical resources, outcome data for the products in the portfolio, and a clear picture of what support they have provided over the past quarter and what they plan to provide in the next.

Synchrocare's medical sales consultants are expected to maintain ongoing clinical engagement with the surgeons they support, not just respond to case-day requests. A quarterly review is the natural structure for that engagement, and it gives both parties a shared accountability framework that improves the relationship over time.

Using the review to plan ahead

The quarterly review is also a planning tool. Upcoming cases with complex anatomy, new procedures you are considering introducing, changes in your patient population that affect device requirements, all of these are conversations that belong in a structured review rather than a hallway conversation before a case.

Surgeons who use the quarterly review as a planning session rather than just a retrospective get more from their distributor relationships because they give their medical sales consultant the lead time to prepare the right resources, arrange the right support, and connect them with the right clinical evidence before they need it.

The next quarter starts now. Is your distributor ready for a review, and are you?

To learn more about Synchrocare's clinical partnership model, visit www.synchrocare.com.